Finally, survival analysis of the above targets identified a statistically significant (p < 0.05) survival curve only for the HOXA10 gene, which is mainly involved in the DIO3OS-hsa-miR-27a-3p-HOXA10 competitive endogenous signaling axis that affects the occurrence and development of ovarian cancer and disease survival. This evidence concerns the gene HOXA10 and ovarian cancer.